Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.36
Delayed Data
As of 1:17pm ET
 +0.311 / +6.16%
Today’s Change
4.91
Today|||52-Week Range
14.59
-4.27%
Year-to-Date

Today’s Trading

Previous close5.05
Today’s open5.41
Day’s range4.97 - 5.41
Volume60,949
Average volume (3 months)175,660
Market cap$128.5M
Dividend yield--
Data as of 1:17pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)+11.59%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratio--
Price/Sales5.59
Price/Book2.00

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...+0.05+1.25%
EVGNEvogene Ltd-0.02-0.39%
PLXProtalix Biotherapeu...0.000.00%
KDMNKadmon Holdings Inc+0.01+0.38%
Data as of 1:20pm ET, 04/26/2017

Financials

Next reporting dateJune 15, 2017
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts


Search for Jobs